Skip Navigation

European Heart Journal 2001 22(6):439-441; doi:10.1053/euhj.2000.2298
Copyright © 2001 by the European Society of Cardiology.
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (6)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Rosano, G.M.C.
Right arrow Articles by Jaillon, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rosano, G.M.C.
Right arrow Articles by Jaillon, P.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Editorials

Hormone replacement therapy: where we stand in Europe

G.M.C. Rosanoa, T. Simonb, G. Mercuroc, S. Sans.d, K. Schenck-Gustaffsone, J.C. Stevensonf, E. Swahng and P. Jaillonb

a Fondazione Centro, S. Raffaele Del Monte Tabor, Rome, Italy
b Faculté de Médecine Saint-Antoine, Paris, France
c Universitá degli Studi di Cagliari, Cagliari, Italy
d Hospital Sant Pau, Barcelona, Spain
e Karolinska Hospital, Stockholm, Sweden
f St Mary's Hospital, London, U.K
g University Hospital, Linkoping, Sweden

References

  1. Vital Statistics of the United States. 1989. Vol II: Morality. Part A. Washington: Government Printing Office; 1993. p. 93–1101
  2. Bush TI, Barret-Connor E, Cowan LD. Cardiovascular mortality and noncontraceptive use of estrogen in women: results from Lipid Research Clinics Program Follow-up Study. Circulation. 1987;75:1102–1109[Abstract/Free Full Text]
  3. Henderson BE, Paganini-Hill A, Ross RK. Decreased moratality in users of estrogen replacement therapy. Arch Intern Med. 1991;151:75–78[Abstract/Free Full Text]
  4. Stampfer MJ, Colditz GA. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Preventive Med. 1991;20:47–63[CrossRef][Web of Science][Medline]
  5. Grodstein F, Stampfer MJ, Mason JE. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. N Engl J Med. 1996;335:453–461[Abstract/Free Full Text]
  6. Grady D, Rubin SM, Petitti DB. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med. 1992;117:1016–1037[Abstract/Free Full Text]
  7. Nachtigall LE, Nachtigall RH, Nachtigall RD, Beckman EM. Estrogen replacement therapy II: a prospective study in the relationship to carcinoma and cardiovascular and metabolic problems. Obstet Gynecol. 1979;54:74–79[Web of Science][Medline]
  8. Falkeborn M, Persson I, Adami HO. The risk of acute myocardial infarction after estrogen and estrogen-progestogen replacement. Br J Obstet Gynecol. 1992;99:821–828[Web of Science][Medline]
  9. Psaty BM, Heckberr SR, Atkins D. The risk of myocardial infarction associated with the combined use of estrogens and progestins in postmenopausal women. Arch Int Med. 1994;154:1333–1339[Abstract/Free Full Text]
  10. Hulley S, Grady D, Bush TA. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. J Am Med Assoc. 1998;280:605–618[Abstract/Free Full Text]
  11. JAMA. 1995;273:199–208[Abstract/Free Full Text]
  12. Adams MR, Clarkson TB, Kaplan JR, Koritnik DR. Ovarian secretions and atherosclerosis. Naftolin F, Gutman JN, DeChemey AH. Ovarian secretion and cardiovascular and neurological function. New York: Raven Press; 1990. p. 151–159
  13. Adams MR, Kaplan JR, Manuck SB. Inhibition of coronary artery atherosclerosis by 17-beta estradiol in ovariectomized monkeys: lack of an effect of added progesterone. Arteriosclerosis. 1990;10:1051–1057[Abstract/Free Full Text]
  14. Barrett-Connor E, Wenger NK, Grady D. Coronary heart disease in women, randomized trials, HERS and RUTH. Maturitas. 1998;31:1–7[CrossRef][Web of Science][Medline]
  15. Bolla M, Mousseau M, Winkel P. Modulation of indications of adjuvant hormone therapy with tamoxifen in T1T2/N0N1 breast cancers. Preliminary results of a multicentre study with 695 cases. Bull Cancer. 1994;81:1085–1090[Web of Science][Medline]
  16. Tunstall-Pedoe H, Kuulasmaa K, Mahonen M. Contribution of trends in survival and coronary event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA populations. Lancet. 1999;353:1547–1557[CrossRef][Web of Science][Medline]
  17. Keil U, Kuulasmaa K. WHO MONICA Project: risk factors. Int J Epidemiol. 1989;18:S46–S55[Abstract]

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Endocr. Rev.Home page
J. L. Turgeon, M. C. Carr, P. M. Maki, M. E. Mendelsohn, and P. M. Wise
Complex Actions of Sex Steroids in Adipose Tissue, the Cardiovascular System, and Brain: Insights from Basic Science and Clinical Studies
Endocr. Rev., October 1, 2006; 27(6): 575 - 605.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
A. R. Genazzani, W. Feeman Jr, L. Mosca, P. Collins, D. M. Herrington, R. C. Pasternak, R. M. Robertson, K. Schenck-Gustafsson, S. C. Smith Jr, K. A. Taubert, et al.
Hormone Replacement Therapy and Cardiovascular Disease: A Statement for Healthcare Professionals From the American Heart Association * Hormone Replacement Therapy and Cardiovascular Disease: A Statement for Healthcare Professionals From the American Heart Association * Response
Circulation, March 26, 2002; 105 (12): e71 - e71.
[Full Text] [PDF]

Home page
 Eur Heart JHome page
S. B. Hulley, V. Bittner, C. Furberg, D. Grady, D. Herrington, E. Vittinghoff, and N. Wenger
Hormone treatment--misconceptions and agreements
Eur. Heart J., January 1, 2002; 23(1): 89 - 90.
[Full Text] [PDF]

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (6)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Rosano, G.M.C.
Right arrow Articles by Jaillon, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rosano, G.M.C.
Right arrow Articles by Jaillon, P.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?